Emu Oil and Saireito in combination reduce tumour development and clinical indicators of disease in a mouse model of colitis-associated colorectal cancer

Ungaro, 2017, Ulcerative colitis, Lancet, 389, 1756, 10.1016/S0140-6736(16)32126-2 Eisenstein, 2018, Ulcerative colitis: towards remission, Nature, 563, S33, 10.1038/d41586-018-07276-2 Biancone, 2019, D. Italian group for the study of inflammatory bowel. Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study, Inflamm. Bowel Dis., 10.1093/ibd/izz155 Herszenyi, 2015, Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk, Dig. Dis., 33, 52, 10.1159/000368447 Klag, 2013, Defective antibacterial barrier in inflammatory bowel disease, Dig. Dis., 31, 310, 10.1159/000354858 Kostic, 2014, The microbiome in inflammatory bowel disease: current status and the future ahead, Gastroenterology, 146, 1489, 10.1053/j.gastro.2014.02.009 Chartier, 2019, Combined nutraceuticals: a novel approach to colitis-associated colorectal cancer?, Nutr. Cancer, 71, 199, 10.1080/01635581.2019.1578391 Ahn, 2015, Effects of Schisandra chinensis extract on gastrointestinal motility in mice, J. Ethnopharmacol., 169, 163, 10.1016/j.jep.2015.03.071 Auyeung, 2016, Astragalus membranaceus: a review of its protection against inflammation and gastrointestinal cancers, Am. J. Chin. Med., 44, 1, 10.1142/S0192415X16500014 Blum, 2019, In vitro activity of neem (Azadirachta indica) oil extract against Helicobacter pylori, J. Ethnopharmacol., 232, 236, 10.1016/j.jep.2018.12.025 Abimosleh, 2012, Emu oil increases colonic crypt depth in a rat model of ulcerative colitis, Dig. Dis. Sci., 57, 887, 10.1007/s10620-011-1979-1 Abimosleh, 2012, Emu Oil: a novel therapeutic for disorders of the gastrointestinal tract?, J. Gastroenterol. Hepatol., 27, 857, 10.1111/j.1440-1746.2012.07098.x Abimosleh, 2013, Emu oil reduces small intestinal inflammation in the absence of clinical improvement in a rat model of indomethacin-induced enteropathy, Evid. Based Complement. Altern. Med., 2013, 1, 10.1155/2013/429706 Chartier, 2018, Emu Oil improves clinical indicators of disease in a mouse model of colitis-associated colorectal cancer, Dig. Dis. Sci., 63, 135, 10.1007/s10620-017-4876-4 Chartier, 2018, Mo1994 - Emu Oil improves clinical indicators of disease and reduces proximal colonic crypt hyperplasia in a murine model of colitis-associated colorectal cancer, Gastroenterology, 154, 10.1016/S0016-5085(18)32957-3 Mashtoub, 2016, Tu1632 Emu Oil attenuates disease severity in mouse models of colitis and inflammation-associated colorectal cancer, Gastroenterology, 150, 10.1016/S0016-5085(16)33896-3 Mashtoub, 2017, Emu Oil attenuates disease severity and results in fewer large colonic tumours in a mouse model of colitis-associated colorectal cancer, Gastroenterology, 152, 10.1016/S0016-5085(17)32559-3 Mashtoub, 2016, Emu Oil combined with lyprinol (TM) reduces small intestinal damage in a rat model of chemotherapy-induced mucositis, Nutr. Cancer Int. J., 68, 1171, 10.1080/01635581.2016.1208829 Mashtoub, 2009, EMU oil increases crypt depth but only minimally affects other indicators of colonic integrity in a rat model of colitis, J. Gastroenterol. Hepatol., 24, A243 Mashtoub, 2013, Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats, Exp. Biol. Med., 238, 1305, 10.1177/1535370213493718 Lindsay, 2010, Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis, Br. J. Nutr., 104, 513, 10.1017/S000711451000084X Yoganathan, 2003, Antagonism of croton oil inflammation by topical emu oil in CD-1 mice, Lipids, 38, 603, 10.1007/s11745-003-1104-y Motoo, 2011, Traditional Japanese medicine, Kampo: its history and current status, Chin. J. Integr. Med., 17, 85, 10.1007/s11655-011-0653-y Nagata, 2016, Anticancer effect of a Kampo preparation Daikenchuto, J. Nat. Med., 70, 627, 10.1007/s11418-016-0989-x Matsunaga, 2017, Protective effect of Daikenchuto on Dextran sulfate sodium-induced colitis in mice, Gastroenterol. Res. Pract., 2017, 1, 10.1155/2017/1298263 Yamakawa, 2013, Role of Kampo medicine in integrative cancer therapy, Evid. Based Complement. Altern. Med., 2013, 1 Borigini, 1996, TJ-114 (Sairei-To), an herbal medicine in rheumatoid arthritis, J. Clin. Rheuma, 2, 309, 10.1097/00124743-199612000-00003 Miki, 2016, Japanese Kampo Saireito has a liver-protective effect through the inhibition of inducible nitric oxide synthase induction in primary cultured rat hepatocytes, JPEN J. Parent. Enter. Nutr., 40, 1033, 10.1177/0148607115575035 Watanabe, 2010, The traditional herbal medicine saireito exerts its inhibitory effect on murine oxazolone-induced colitis via the induction of Th1-polarized immune responses in the mucosal immune system of the colon, Int. Arch. Allergy Immunol., 151, 98, 10.1159/000235999 Hardardottir, 2015, Dendritic cells matured in the presence of the lycopodium alkaloid annotine direct T cell responses toward a Th2/Treg phenotype, Phytomed. Int. J. Phytother. Phytopharm., 22, 277 Becker, 2005, In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy, Gut, 54, 950, 10.1136/gut.2004.061283 Jirkof, 2013, Burrowing is a sensitive behavioural assay for monitoring general wellbeing during dextran sulfate sodium colitis in laboratory mice, Lab Anim., 47, 274, 10.1177/0023677213493409 Ballard, 2002, Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity, J. Neurosci., 22, 6713, 10.1523/JNEUROSCI.22-15-06713.2002 Browne, 2012, An effective dietary method for chronic tryptophan depletion in two mouse strains illuminates a role for 5-HT in nesting behaviour, Neuropharmacology, 62, 1903, 10.1016/j.neuropharm.2011.12.009 Yazbeck, 2008, Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice, Front. Biosci., 13, 6850, 10.2741/3193 Becker, 2006, High resolution colonoscopy in live mice, Nat. Protoc., 1, 2900, 10.1038/nprot.2006.446 Huang, 2002, Colonoscopy in mice, Surg. Endosc., 16, 22, 10.1007/s004640080168 Lippert, 2017, Anthocyanins prevent colorectal cancer development in a mouse model, Digestion, 95, 275, 10.1159/000475524 Seiwert, 2020, Curcumin administered as micellar solution suppresses intestinal inflammation and colorectal carcinogenesis, Nutr. Cancer, 73, 686, 10.1080/01635581.2020.1771384 Sharp, 2018, DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer, Gene, 677, 299, 10.1016/j.gene.2018.08.016 Gao, 2012, Evidence-based research on traditional Japanese medicine, Kampo, in treatment of gastrointestinal cancer in Japan, Drug Disco Ther., 6, 1 Ikegami, 2006, Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use, Hum. Exp. Toxicol., 25, 481, 10.1191/0960327106het654oa Yoshikawa, 2012, The effects of the Kampo medicine (Japanese herbal medicine) “Daikenchuto” on the surgical inflammatory response following laparoscopic colorectal resection, Surg. Today, 42, 646, 10.1007/s00595-011-0094-4 Kato, 2015, Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells, PLoS One, 10, 10.1371/journal.pone.0116213 Wang, 2016, American ginseng attenuates colitis-associated colon carcinogenesis in mice: impact on gut microbiota and metabolomics, Cancer Prev. Res., 9, 803, 10.1158/1940-6207.CAPR-15-0372 Wen, 2014, Panax notoginseng attenuates experimental colitis in the azoxymethane/dextran sulfate sodium mouse model, Phytother. Res., 28, 892, 10.1002/ptr.5066 Waldner, 2014, Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development, Semin. Immunol., 26, 75, 10.1016/j.smim.2013.12.003 Lahm, 1992, Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1, Eur. J. Cancer, 28A, 1894, 10.1016/0959-8049(92)90031-V Grivennikov, 2009, IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer, Cancer Cell, 15, 103, 10.1016/j.ccr.2009.01.001 Waldner, 2008, Cytokines in colitis associated cancer: potential drug targets?, Inflamm. Allergy Drug Targets, 7, 187, 10.2174/187152808785748137 Jirkof, 2014, Burrowing and nest building behavior as indicators of well-being in mice, J. Neurosci. Methods, 234, 139, 10.1016/j.jneumeth.2014.02.001 Chartier, 2020, Affective state determination in a mouse model of colitis-associated colorectal cancer, PLoS One, 15, 10.1371/journal.pone.0228413 Deacon, 2003, Effects of medial prefrontal cortex cytotoxic lesions in mice, Behav. Brain Res., 139, 139, 10.1016/S0166-4328(02)00225-5 Paumier, 2013, Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson’s disease, PLoS One, 8, 10.1371/journal.pone.0070274 George, 2018, A judgement bias test to assess affective state and potential therapeutics in a rat model of chemotherapy-induced mucositis, Sci. Rep., 8, 8193, 10.1038/s41598-018-26403-7